X.T.L. Biopharmaceuticals Ltd

XTLB NASDAQ Santé & Biotech Israël US98386D3070
2.03 $
11.74 %

Entreprise biopharmaceutique développant des thérapies pour le traitement des troubles neurodégénératifs.

Performance & Momentum

6 Months 33.29 %
1 Year 52.43 %
3 Years 53.19 %
5 Years 83.18 %

Similar stocks to X.T.L. Biopharmaceuticals Ltd

Anantys Community

Be the first to share your analysis on X.T.L. Biopharmaceuticals Ltd.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases